Detection of invasive protein profile of Streptococcus pyogenes M1 isolates from pharyngitis patients

APMIS

Volumn 118, Issue 3, 2010, Pages 167-178

  Hasegawa, Tadao ^a   Okamoto, Akira ^b   Kamimura, Takuya ^b   Tatsuno, Ichiro ^a   Hashikawa, Shin Nosuke ^b   Yabutani, Mitsutaka ^c   Matsumoto, Masakado ^d   Yamada, Keiko ^b   Isaka, Masanori ^a   Minami, Masaaki ^a   Ohta, Michio ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA CITY PUBLIC HEALTH RESEARCH INSTITUTE   (Japan)

^d AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

2 DE; CovS; M1; Pharyngitis; Streptococcus pyogenes

Indexed keywords

BACTERIAL PROTEIN; EXOTOXIN; PROTEIN COVS; STREPTOCOCCAL PYROGENIC EXOTOXIN B; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCAL TOXIC SHOCK SYNDROME; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; PHARYNGITIS; STREPTOCOCCUS PYOGENES;

EID: 76149113909     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02574.x     Document Type: Article

References (47)

1. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987 317 : 146 149.
2. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989 321 : 1 7.
3. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990 336 : 1167 1171.
4. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992 14 : 2 11.
5. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993 269 : 384 389.
6. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991 88 : 2668 2672.
7. Stevens DL. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994 13 : 561 566.
8. Stevens DL, Salmi DB, McIndoo ER, Bryant AE. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome. J Infect Dis 2000 182 : 1117 1128.
9. Shimizu Y, Ohyama A, Kasama K, Miyazaki M, Ooe K, Ookochi Y. Case report of toxic shock-like syndrome due to group A streptococcal infection. Kansenshogaku Zasshi 1993 67 : 236 239.
10. Shimizu Y, Igarashi H, Murai T, Ohkuni H, Watanabe H, Uchiyama T, et al. Report of surveillance on streptococcal toxic shock syndrome in Japan and presentation of the criteria. Kansenshogaku Zasshi 1998 72 : 258 265.
11. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 1993 269 : 390 391.
12. Eriksson BK, Andersson J, Holm SE, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 1998 27 : 1428 1436.
13. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000 13 : 470 511.
14. Tyrrell GJ, Lovgren M, Forwick B, Hoe NP, Musser JM, Talbot JA. M types of group A streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol 2002 40 : 4466 4471.
15. Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam R, Schwartz B, et al. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis 1998 27 : 150 157.
16. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992 339 : 518 521.
17. Muotiala A, Seppala H, Huovinen P, Vuopio-Varkila J. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis 1997 175 : 392 399.
18. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995 63 : 994 1003.
19. Okuno R, Endoh M, Shimojima Y, Yanagawa Y, Morozumi S, Igarashi H, et al. Epidemiological study on Streptococcus pyogenes strains isolated from the patients with streptococcal toxic shock syndrome (STSS) in Japan in 1992-2001. Kansenshogaku Zasshi 2004 78 : 10 7.
20. Ikebe T, Murai N, Endo M, Okuno R, Murayama S, Saitoh K, et al. Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan. Epidemiol Infect 2003 130 : 569 572.
21. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 2001 98 : 4658 4663.
22. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 2005 192 : 771 782.
23. Aziz RK, Edwards RA, Taylor WW, Low DE, McGeer A, Kotb M. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol 2005 187 : 3311 3318.
24. Hasegawa T, Torii K, Hashikawa S, Iinuma Y, Ohta M. Cloning and characterization of two novel DNases from Streptococcus pyogenes. Arch Microbiol 2002 177 : 451 456.
25. Hasegawa T, Torii K, Hashikawa S, Iinuma Y, Ohta M. Cloning and characterization of the deoxyribonuclease sdα gene from Streptococcus pyogenes. Curr Microbiol 2002 45 : 13 7.
26. Nakamura T, Hasegawa T, Torii K, Hasegawa Y, Shimokata K, Ohta M. Two-dimensional gel electrophoresis analysis of the abundance of virulent exoproteins of group A streptococcus caused by environmental changes. Arch Microbiol 2004 181 : 74 81.
27. Tanaka M, Hasegawa T, Okamoto A, Torii K, Ohta M. Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis. Antimicrob Agents Chemother 2005 49 : 88 96.
28. Sawai J, Hasegawa T, Kamimura T, Okamoto A, Ohmori D, Nosaka N, et al. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob Agents Chemother 2007 51 : 461 467.
29. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2006 2 : e5.
30. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, et al. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 2007 13 : 981 985.
31. Hashikawa S, Iinuma Y, Furushita M, Ohkura T, Nada T, Torii K, et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 2004 42 : 186 192.
32. Okada N, Tatsuno I, Hanski E, Caparon M, Sasakawa C. Streptococcus pyogenes protein F promotes invasion of HeLa cells. Microbiology 1998 144 : 3079 3086.
33. Bohach GA, Hauser AR, Schlievert PM. Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli. Infect Immun 1988 56 : 1665 1667.
34. Akesson P, Sjoholm AG, Bjorck L. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 1996 271 : 1081 1088.
35. Hoe NP, Vuopio-Varkila J, Vaara M, Grigsby D, De Lorenzo D, Fu YX, et al. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J Infect Dis 2001 183 : 633 639.
36. Engleberg NC, Heath A, Miller A, Rivera C, DiRita VJ. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 2001 183 : 1043 1054.
37. Levin JC, Wessels MR. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 1998 30 : 209 219.
38. Federle MJ, McIver KS, Scott JR. A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol 1999 181 : 3649 3657.
39. Heath A, DiRita VJ, Barg NL, Engleberg NC. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 1999 67 : 5298 5305.
40. Shelburne SA III., Granville C, Tokuyama M, Sitkiewicz I, Patel P, Musser JM. Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect Immun 2005 73 : 4723 4731.
41. Nyberg P, Rasmussen M, Bjorck L. α2-macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem 2004 279 : 52820 52823.
42. Collin M, Svensson MD, Sjoholm AG, Jensenius JC, Sjobring U, Olsen A. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 2002 70 : 6646 6651.
43. Eriksson A, Norgren M. Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun 2003 71 : 211 217.
44. Virtaneva K, Porcella SF, Graham MR, Ireland RM, Johnson CA, Ricklefs SM, et al. Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci USA 2005 102 : 9014 9019.
45. Dalton TL, Scott JR. CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes. J Bacteriol 2004 186 : 3928 3937.
46. Froehlich BJ, Bates C, Scott JR. Streptococcus pyogenes CovRS mediates growth in iron starvation and in the presence of the human cationic antimicrobial peptide LL-37. J Bacteriol 2009 191 : 673 677.
47. 2+. Proc Natl Acad Sci USA 2003 100 : 4227 4232.